The Mary Bird Perkins Cancer Center and The NeuroMedical Center have entered into a new research agreement that will begin with the launch of a clinical trial for newly diagnosed glioblastoma, or GBM, patients. GBM is an aggressive type of cancer that begins in the brain, with approximately 12,000 cases diagnosed in the U.S. each
Mary Bird Perkins, NeuroMedical Center form research partnership
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
